Open AccessVaginal microbicides: An overview
Author(s) -
Hany AbdelAleem
Publication year - 2011
Publication title -
middle east fertility society journal/middle east fertility society journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 18
eISSN - 2090-3251
pISSN - 1110-5690
DOI - 10.1016/j.mefs.2010.08.008
Subject(s) - microbicide , microbicides for sexually transmitted diseases , vaginal microbicide , medicine , transmission (telecommunications) , human immunodeficiency virus (hiv) , gynecology , environmental health , obstetrics , intensive care medicine , family medicine , population , health services , engineering , electrical engineering
It is estimated that more than 340 million new cases of curable sexually transmitted infections occur every year throughout the world in men and women age (15–49years). Women bear an increasing burden of the epidemic as both caregivers for the ill and because of their heightened risk of infection due to biological, economic and social vulnerabilities. There is an urgent need for new prevention strategies that women can use themselves and initiate. A vaginal microbicide defined as substances intended to reduce or prevent transmission of HIV and/or other sexually transmitted infections (STIs) when applied topically to genital mucosal surfaces, provides a woman-controlled method applied before sex that could kill, neutralize, or block HIV and other sexually transmitted diseases